Navitas Assets (Cicletanine Business) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Navitas Assets (Cicletanine Business) General Information

Description

Developer of hypertension drug. The company develops and produces drug, oral drug agents and treatments for pulmonary arterial hypertension.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Acquirer
Gilead Sciences
Primary Office
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Navitas Assets (Cicletanine Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Navitas Assets (Cicletanine Business)‘s full profile, request access.

Request a free trial

Navitas Assets (Cicletanine Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Navitas Assets (Cicletanine Business)‘s full profile, request access.

Request a free trial